Pokushalov, E.; Ponomarenko, A.; Garcia, C.; Pak, I.; Shrainer, E.; Seryakova, M.; Johnson, M.; Miller, R.
The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2024, 16, 557.
https://doi.org/10.3390/nu16040557
AMA Style
Pokushalov E, Ponomarenko A, Garcia C, Pak I, Shrainer E, Seryakova M, Johnson M, Miller R.
The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2024; 16(4):557.
https://doi.org/10.3390/nu16040557
Chicago/Turabian Style
Pokushalov, Evgeny, Andrey Ponomarenko, Claire Garcia, Inessa Pak, Evgenya Shrainer, Mariya Seryakova, Michael Johnson, and Richard Miller.
2024. "The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial" Nutrients 16, no. 4: 557.
https://doi.org/10.3390/nu16040557
APA Style
Pokushalov, E., Ponomarenko, A., Garcia, C., Pak, I., Shrainer, E., Seryakova, M., Johnson, M., & Miller, R.
(2024). The Impact of Glucomannan, Inulin, and Psyllium Supplementation (SolowaysTM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 16(4), 557.
https://doi.org/10.3390/nu16040557
